Literature DB >> 32768397

Reasons for hormonal contraceptive use in a cohort of African-American women living in the Detroit area.

Sarah R Hoffman1, Wanda K Nicholson2, Jennifer S Smith3, Michele Jonsson Funk3, Michael G Hudgens4, Charles Poole3, Donna D Baird5, Quaker E Harmon5.   

Abstract

OBJECTIVES: To characterize reasons for hormonal contraceptive (HC) use in 1,455 African-American women, aged 23-35 years. STUDY
DESIGN: The community-based cohort members were recruited from the Detroit, Michigan area in 2010-2012. HC history was collected via telephone interview.
RESULTS: Seven percent reported HC use exclusively for non-contraceptive purposes, and 49% reported non-contraceptive reasons in addition to contraception. Non-contraceptive reasons were reported for all HC types, but were most common for combined oral contraceptives. Primary reasons were for irregular cycles, heavy bleeding, and pain.
CONCLUSIONS: In this large cohort of Black women, HC use to treat menstrual problems was common. IMPLICATIONS: HCs were commonly used for both pregnancy prevention and management of menstrual symptoms, but some women used HCs exclusively for menstrual symptom relief. The importance for women of non-contraceptive reasons for HC use may not be adequately recognized, and published data on Black women's reasons for HC use remain limited.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depo-Provera; Hormonal contraceptive(s); Implant; Intrauterine device(s); Oral contraceptives; Patch

Year:  2020        PMID: 32768397      PMCID: PMC7606661          DOI: 10.1016/j.contraception.2020.07.093

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  8 in total

1.  Choice of birth control methods among European women and the role of partners and providers.

Authors:  Jokin de Irala; Alfonso Osorio; Silvia Carlos; Cristina Lopez-del Burgo
Journal:  Contraception       Date:  2011-06-08       Impact factor: 3.375

2.  Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.

Authors:  Christine Troskie; Judith A Soon; Arianne Y Albert; Wendy V Norman
Journal:  CMAJ Open       Date:  2016-11-03

3.  Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women.

Authors:  Q E Harmon; D D Baird
Journal:  Hum Reprod       Date:  2015-03-27       Impact factor: 6.918

4.  Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995.

Authors:  Jo Jones; William Mosher; Kimberly Daniels
Journal:  Natl Health Stat Report       Date:  2012-10-18

5.  Contraceptive methods women have ever used: United States, 1982-2010.

Authors:  Kimberly Daniels; William D Mosher
Journal:  Natl Health Stat Report       Date:  2013-02-14

6.  A Prospective, Ultrasound-Based Study to Evaluate Risk Factors for Uterine Fibroid Incidence and Growth: Methods and Results of Recruitment.

Authors:  Donna D Baird; Quaker E Harmon; Kristen Upson; Kristen R Moore; Christie Barker-Cummings; Susan Baker; Tracy Cooper; Ganesa Wegienka
Journal:  J Womens Health (Larchmt)       Date:  2015-09-03       Impact factor: 2.681

7.  Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013.

Authors:  Kimberly Daniels; Jill Daugherty; Jo Jones; William Mosher
Journal:  Natl Health Stat Report       Date:  2015-11-10

8.  Observational, prospective, multicentre study to evaluate the effects of counselling on the choice of combined hormonal contraceptives in Italy--the ECOS (Educational COunselling effectS) study.

Authors:  Alessandro Gambera; Fedela Corda; Rosetta Papa; Carlo Bastianelli; Sandra Bucciantini; Salvatore Dessole; Pasquale Scagliola; Nadia Bernardini; Daniela de Feo; Fabiola Beligotti
Journal:  BMC Womens Health       Date:  2015-09-02       Impact factor: 2.809

  8 in total
  1 in total

1.  Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.

Authors:  Quaker E Harmon; Stacy A Patchel; Shanshan Zhao; David M Umbach; Tracy E Cooper; Donna D Baird
Journal:  Obstet Gynecol       Date:  2022-04-05       Impact factor: 7.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.